Last reviewed · How we verify
Routine deworming
At a glance
| Generic name | Routine deworming |
|---|---|
| Also known as | albendazole |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Women Supporting Women to Improve Infant and Child Feeding Practices in Pakistan (NA)
- Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP) (NA)
- Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study
- Nutrition and Inflammation in Pregnancy: Impacts on Early Human Brain Development in Ethiopia
- Evaluating Impact of Improved Floors on Health (NA)
- Mobile Health (mHealth) Tools to Improve Delivery Quality of a Family Home Visiting Intervention (NA)
- Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth Programs
- Sustainable Undernutrition Reduction in Ethiopia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Routine deworming CI brief — competitive landscape report
- Routine deworming updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI